Loading...
Development of Novel Radiosensitizers through the National Cancer Institute’s Small Business Innovation Research Program
While radiosensitizing chemotherapy has improved survival for several types of cancer, current chemoradiation regimens remain ineffective for many patients and have substantial toxicities. Given the strong need for the development of novel radiosensitizers to further improve patient outcomes, the Ra...
Na minha lista:
| Udgivet i: | Radiat Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7266046/ https://ncbi.nlm.nih.gov/pubmed/32216707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR15545.1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|